Congressman George Santos Apparently Lied About Helping Kids Living with Epidermolysis Bullosa
source: unsplash.com

Congressman George Santos Apparently Lied About Helping Kids Living with Epidermolysis Bullosa

According to a story from VICE News, Congressman George Santos was recently elected to Congress in the 2022 mid-term elections. Since then, his past has been placed under scrutiny, and…

Continue Reading Congressman George Santos Apparently Lied About Helping Kids Living with Epidermolysis Bullosa
Trial Application for Experimental Cannabinoid Epidermolysis Bullosa Treatment Gains Approval
source: pixabay.com

Trial Application for Experimental Cannabinoid Epidermolysis Bullosa Treatment Gains Approval

According to a story from prnewswire.com, the biopharmaceutical company InMed Pharmaceuticals, Inc. has recently announced that that company's Clinical Trial Application has been approved in the Netherlands. This approval will…

Continue Reading Trial Application for Experimental Cannabinoid Epidermolysis Bullosa Treatment Gains Approval

Results From First Patient Treated in Epidermolysis Bullosa Phase 2 Trial are Extremely Promising

Epidermolysis Bullosa Epidermolysis bullosa (EB) is a rare condition affecting approximately 500,000 individuals globally. Patients in the United States and Europe account for 50,000 of these individuals. The hereditary condition is…

Continue Reading Results From First Patient Treated in Epidermolysis Bullosa Phase 2 Trial are Extremely Promising

Phase 2 Trial Results for Epidermolysis Bullosa Coming Second Quarter of 2019

Epidermolysis Bullosa Epidermolysis Bullosa (EB) refers to a group of rare conditions which are characterized by fragile skin. Basically, the disease is caused by separation between the layers of the skin.…

Continue Reading Phase 2 Trial Results for Epidermolysis Bullosa Coming Second Quarter of 2019
Phase 1 Gene Transfer Trial for Recessive Dystrophic Epidermolysis Bullosa is Recruiting Patients
PixLoger / Pixabay

Phase 1 Gene Transfer Trial for Recessive Dystrophic Epidermolysis Bullosa is Recruiting Patients

According to a story from Debra of America, a new Phase 1 clinical trial being operated by Stanford University is currently recruiting participants. This trial will be a test of…

Continue Reading Phase 1 Gene Transfer Trial for Recessive Dystrophic Epidermolysis Bullosa is Recruiting Patients
Drug Developer Receives $900,000 for the Development of a Gene Therapy for Epidermolysis Bullosa
ColiN00B / Pixabay

Drug Developer Receives $900,000 for the Development of a Gene Therapy for Epidermolysis Bullosa

According to a story from pm360online.com, the gene therapy company Fibrocell Science, Inc., recently received an investment of $900,000 from the Epidermolysis Bullosa Medical Research Foundation (EBMRF) and the EB…

Continue Reading Drug Developer Receives $900,000 for the Development of a Gene Therapy for Epidermolysis Bullosa
This Company Will Work With Nonprofit Organizations to Develop New Treatment for Epidermolysis Bullosa
DarkoStojanovic / Pixabay

This Company Will Work With Nonprofit Organizations to Develop New Treatment for Epidermolysis Bullosa

According to a story from PR Newswire, the biopharmaceutical company Constant Pharmaceuticals recently announced that it plans to develop its experimental compound TXA127 as a therapy for epidermolysis bullosa (EB).…

Continue Reading This Company Will Work With Nonprofit Organizations to Develop New Treatment for Epidermolysis Bullosa

Debra of America’s 2018 Debra Care Conference

  • Post author:
  • Post category:

This event will be an opportunity for epidermyolsis bullosa patients and their families to network with one another. Participants will also be able to learn about the latest in epidermyolsis…

Continue Reading Debra of America’s 2018 Debra Care Conference